We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Light and Ultrasound Waves Reveal Extent of Skin Cancer

By MedImaging International staff writers
Posted on 11 Dec 2017
Print article
Image: A 3D rendering of a basal cell carcinoma lesion (melanin in yellow, hemoglobin in blue, and oxyhemoglobin in red) (Photo courtesy of M. Olive et al).
Image: A 3D rendering of a basal cell carcinoma lesion (melanin in yellow, hemoglobin in blue, and oxyhemoglobin in red) (Photo courtesy of M. Olive et al).
A new study demonstrates that multispectral optoacoustic tomography (MSOT) allows three-dimensional (3D) imaging of deep non-melanoma skin tumors (NMSCs).

Developed by the Singapore Bioimaging Consortium (SBIC), Munich Technical University (TUM; Germany), the Skin Research Institute of Singapore (SRIS), and other institutions, MSOT is a volumetric imaging technique that can be used to differentiate between tissue chromophores and exogenous contrast agents based on differences in their spectral signatures, and which can provide high-resolution imaging of functional and molecular contrast at centimeter scale depth, providing more precise Mohs micrographic surgery (MMS).

The researchers used handheld MSOT probes for 3D imaging in 21 Asian patients with NMSC. The results showed that both tumors and their oxygenation parameters could be distinguished from normal skin endogenously. Lesion dimensions were extracted from the MSOT spectral melanin component with 3D spatial resolution of up to 80 μm, with good correlation to histology of the excised tumors. Real-time 3D imaging also provided data on lesion morphology and the neovasculature, both indicators of the tumor’s aggressiveness. The study was published in the September 2017 issue of Photoacoustics.

“As skin cancer becomes increasingly prevalent, new skin imaging techniques providing non-invasive visualization without the need for excisional skin biopsy can help dermatologists plan the excision surgeries more effectively and accurately,” said lead author Professor Malini Olivo, PhD, head of the bio-optical imaging group at SBIC. “This positively impacts the long-term outcome of these procedures. This first-in-man study has successfully demonstrated that the use of MSOT can vastly improve the accuracy of the diagnosis and effectiveness of the treatment of non-melanoma skin cancer.”

“The ability to image skin cancer in 3D in-vivo will prove to be the disruptive technology for skin cancer management in the future,” concluded senior author Professor Steven Thng, executive director of SRIS. “This will change the paradigm of how skin cancer will be managed, as dermatosurgeons will now be able to visualize the tumor before surgery and individualize surgery based on tumor characteristics and size. This will minimize relapse rates due to inadequate surgery, and reduce unnecessary scarring because of oversampling.”

MMS is a surgical technique for the removal of certain cutaneous carcinomas that allows precise microscopic marginal control. It has become the treatment of choice for several NMSCs, such as basal cell and squamous cell carcinomas at high risk for local recurrence. Advantages of MMS include superior cure rates, maximal tissue conservation, low cost relative to that of radiation therapy, excision, or surgery, and negligible risk of complications from general anesthesia.

Related Links:
Singapore Bioimaging Consortium
Munich Technical University
Skin Research Institute of Singapore
Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
DR Flat Panel Detector
1500L
New
Ultrasound Needle Guide
Ultra-Pro II
New
Ultrasound Table
Powered Ultrasound Table-Flat Top

Print article

Channels

Radiography

view channel
:	Image: The AI model could be a valuable adjunct to human radiologists in breast cancer diagnoses and risk prediction (Photo courtesy of 123RF)

AI Model Predicts 5-Year Breast Cancer Risk from Mammograms

Approximately 13% of U.S. women, or one in every eight, are predicted to develop invasive breast cancer over their lifetime, with 1 in 39 women (3%) succumbing to the illness, according to the American... Read more

Nuclear Medicine

view channel
Image: The AI system uses scintigraphy imaging for early diagnosis of cardiac amyloidosis (Photo courtesy of 123RF)

AI System Automatically and Reliably Detects Cardiac Amyloidosis Using Scintigraphy Imaging

Cardiac amyloidosis, a condition characterized by the buildup of abnormal protein deposits (amyloids) in the heart muscle, severely affects heart function and can lead to heart failure or death without... Read more

General/Advanced Imaging

view channel
Image: The Cinematic Reality app enables interaction with realistic renderings of human anatomy (Photo courtesy of Siemens)

AR Application Turns Medical Scans Into Holograms for Assistance in Surgical Planning

Siemens Healthineers (Erlangen, Germany) has launched an app designed for Apple Vision Pro that allows users including surgeons, medical students, or patients to view immersive, interactive holograms of... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more

Industry News

view channel
Image: Samsung Medison CEO Mr. Yongkwan Kim and Bracco Imaging CEO Dr. Fulvio Renoldi Bracco endorsed a MoU agreement (Photo courtesy of Bracco Group)

Samsung and Bracco Enter Into New Diagnostic Ultrasound Technology Agreement

Samsung Medison (Seoul, South Korea) and Bracco Imaging (Milan, Italy) have entered into a Memorandum of Understanding (MoU) agreement to pioneer a new area for diagnostic ultrasound devices and contrast agents.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.